Our model’s prediction of SLC25A1’s essentiality in hypoxic tumor cells is substantiated by prior findings that SLC25A1 expression is up-regulated when prostate cancer cells are exposed to cycling hypoxia/re-oxygenation stress74. The gene discussed is SLC25A1; the disease is prostate carcinoma.